Anderson Cynthia Lynn 4
4 · Vistagen Therapeutics, Inc. · Filed Jul 1, 2025
Insider Transaction Report
Form 4
Anderson Cynthia Lynn
CHIEF FINANCIAL OFFICER
Transactions
- Award
Common Stock
2025-06-30$1.70/sh+6,617$11,249→ 12,801 total
Footnotes (1)
- [F1]The Reporting Person is voluntarily reporting the acquisition of shares under the Issuer's 2019 Employee Stock Purchase Plan, as amended, in a transaction exempt under Rule 16b-3(c) and Rule 16b-3(d).